Financial

  • Aug. 30, 2014 biOasis Closes Non-Brokered Private Placement for $1,609,753.15 Gross Proceeds

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI) (the “Company”) is please to announce it has closed its non-brokered private placement announced on August 8th, 2014. The Company has issued 1,694,447 units (each a “Unit”), including an over allotment of 94,477 Units, at a price of CDN$0.95 per unit, for gross proceeds of CDN$1,609,753.15.… Read more »

  • Aug. 9, 2014 biOasis Announces Non-Brokered Private Placement

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQX: BIOAF)(the “Company”) announces a non-brokered private placement of up to 1,600,000 units (each a “Unit”) at a price of $0.95 per Unit of gross proceeds of up to $1,520,000 with an overallotment of up to 20%. Each Unit will consist of one common share and one… Read more »

  • May. 8, 2014 biOasis Secures DTC Eligibility

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (OTCQX:BIOAF) (TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, today announced that it has secured DTC eligibility by The Depository Trust Company (DTC) for its shares traded on the OTCQX® under the symbol BIOAF. The DTC is a… Read more »

  • Feb. 24, 2014 biOasis to Begin Trading on OTCQX® Marketplace in the U.S.

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (OTCQX:BIOAF) (TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, has up listed on the highest tier of the off- market, OTCQX® under the symbol BIOAF. “Joining the OTCQX brings greater visibility and awareness of biOasis to the US… Read more »

  • Dec. 4, 2013 Option Grant – biOasis Technologies Inc.

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX: V BTI) (the “Company”) announces that, pursuant to the terms of its Stock Option Plan, the company has granted a total of 1,700,000 options to its officers, employees, consultants and members of the board of directors. 1,550,000 of the options are exercisable at a price of $0.97… Read more »

  • Jun. 19, 2013 CEO Letter to Shareholders

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (BTI.V) an industry-leading provider of technology to potentially deal with the unmet medical need of shuttling therapeutic compounds across the Blood-Brain Barrier, with its’ Transcend technology, issued the following letter: Dear fellow biOasis Shareholders: The past 12 months have been marked by a number of significant accomplishments. I… Read more »

  • Feb. 13, 2013 biOasis named to 2013 TSX Venture 50®

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V.BTI) announces it has been named one of the 2013 TSX Venture 50® companies. The 2013 TSX Venture 50® includes the top 10 companies in 5 major industry sectors that have been identified as leaders in providing shareholder value on Canada’s junior stock exchange. “We are very proud… Read more »

  • Aug. 28, 2012 2012-2013 Board of Directors election, Officers appointment and Option Grant

    Vancouver, B.C.–(Business Wire)– biOasis Technologies Inc. (TSX: V BTI) announces its board of directors elected by the shareholders at its Annual General Meeting held today: Robin HutchisonDavid Clark,CADr. Terry PearsonDr. Chris FibigerMichael Hutchison Q.C.Ron EricksonGreg Gubitz The Board also appointed the following officers of the Company: Robin Hutchison, President and CEODavid Clark, Chief Financial Officer… Read more »

  • Jul. 19, 2012 Option Grant – biOasis Technologies Inc.

    Vancouver, B.C.–(Business Wire)– biOasis Technologies Inc. (TSX: V BTI) announces that is has granted options to its officers, employees, consultants and members of the board of directors. A total of 1,647,000 options have been granted in accordance with the approved stock option plan, effective at the close of business on July 19, 2012 at a… Read more »

  • May. 31, 2012 biOasis Announces Grant of Stock Options to IR Providers

    Vancouver, B.C.–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) announces that subject to regulatory approval it will grant additional options in the amount of 50,000 to Brisco Capital Partners Corp. and 50,000 to Graeme Dick pursuant to their IR Consulting Agreement as amended as well as 50,000 to Hamza Thindal Capital Corporation pursuant to their Marketing… Read more »